Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nature Neuroscience, vol.125, issue.12, pp.1538-1543, 2007. ,
DOI : 10.1038/nn2014
Immune reactivity in a mouse model of familial ALS correlates with disease progression, Neurology, vol.57, issue.7, pp.1282-1289, 2001. ,
DOI : 10.1212/WNL.57.7.1282
Inducible Nitric Oxide Synthase Up-Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis, Journal of Neurochemistry, vol.291, issue.6, pp.2415-2425, 1999. ,
DOI : 10.1046/j.1471-4159.1999.0722415.x
Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis, Annals of Neurology, vol.155, issue.2, pp.176-185, 2001. ,
DOI : 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X
The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration, Neuroscience, vol.42, issue.1, pp.201-214, 1991. ,
DOI : 10.1016/0306-4522(91)90159-L
Lack of evidence for HTLV tax-rex DNA in motor neurone disease, Journal of the Neurological Sciences, vol.153, issue.1, pp.86-90, 1997. ,
DOI : 10.1016/S0022-510X(97)00199-8
Detection of reverse transcriptase activity in the serum of patients with motor neurone disease, Journal of Medical Virology, vol.129, issue.4, pp.527-532, 2000. ,
DOI : 10.1002/1096-9071(200008)61:4<527::AID-JMV17>3.0.CO;2-A
Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis, Proceedings of the National Academy of Sciences, vol.100, issue.8, pp.4790-4795, 2003. ,
DOI : 10.1073/pnas.0530191100
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis, Neurology, vol.71, issue.17, pp.1326-1334, 2008. ,
DOI : 10.1212/01.wnl.0000327668.43541.22
Evidence for autoimmunity in amyotrophic lateral sclerosis, Journal of the Neurological Sciences, vol.118, issue.2, pp.169-174, 1993. ,
DOI : 10.1016/0022-510X(93)90106-9
Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice, PLoS ONE, vol.10, issue.7, p.18648532, 2008. ,
DOI : 10.1371/journal.pone.0002740.s002
A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis, Brain Research Reviews, vol.47, issue.1-3, pp.263-274, 2004. ,
DOI : 10.1016/j.brainresrev.2004.05.003
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1762, issue.11-12, pp.1051-1067, 2006. ,
DOI : 10.1016/j.bbadis.2006.03.008
Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis, Muscle & Nerve, vol.144, issue.4, pp.541-544, 2005. ,
DOI : 10.1002/mus.20376
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology, Physiological Reviews, vol.87, issue.1, pp.245-313, 2007. ,
DOI : 10.1152/physrev.00044.2005
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis, Proceedings of the National Academy of Sciences, vol.103, issue.43, pp.16021-16026, 2006. ,
DOI : 10.1073/pnas.0607423103
CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS, Proceedings of the National Academy of Sciences, vol.105, issue.40, pp.15558-15563, 2008. ,
DOI : 10.1073/pnas.0807419105
Delayed hematopoietic development in osteopetrotic (op/op) mice, Journal of Experimental Medicine, vol.177, issue.1, pp.237-242, 1993. ,
DOI : 10.1084/jem.177.1.237
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease, Proceedings of the National Academy of Sciences, vol.101, issue.25, pp.9435-9440, 2004. ,
DOI : 10.1073/pnas.0400569101
Microglial control of neuronal death and synaptic properties, Glia, vol.115, issue.3, pp.233-238, 2007. ,
DOI : 10.1002/glia.20459
Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls, European Journal of Neurology, vol.24, issue.12, pp.1340-1345, 2006. ,
DOI : 10.1016/S0166-2236(98)01261-2
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors, Neuron, vol.52, issue.1, pp.39-59, 2006. ,
DOI : 10.1016/j.neuron.2006.09.018
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia, Science, vol.312, issue.5778, pp.1389-1392, 2006. ,
DOI : 10.1126/science.1123511
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis, Neurology, vol.51, issue.2, pp.583-586, 1998. ,
DOI : 10.1212/WNL.51.2.583
Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis., Journal of Neurology, Neurosurgery & Psychiatry, vol.50, issue.6, pp.792-794, 1987. ,
DOI : 10.1136/jnnp.50.6.792
Protective action of the peroxisome proliferator-activated receptor-?? agonist pioglitazone in a mouse model of Parkinson's disease, Journal of Neurochemistry, vol.178, issue.18, pp.615-624, 2002. ,
DOI : 10.1046/j.1471-4159.2002.00990.x
ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions, Neuron, vol.18, issue.2, pp.327-338, 1997. ,
DOI : 10.1016/S0896-6273(00)80272-X
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1, Proceedings of the National Academy of Sciences, vol.103, issue.31, pp.11784-11789, 2006. ,
DOI : 10.1073/pnas.0604681103
Control of microglial neurotoxicity by the fractalkine receptor, Nature Neuroscience, vol.24, issue.7, pp.917-924, 2006. ,
DOI : 10.1038/nn1715
Minocycline for patients with ALS, The Lancet Neurology, vol.7, issue.2, pp.118-119, 2008. ,
DOI : 10.1016/S1474-4422(08)70005-X
TNF and sTNFR1/2 plasma levels in ALS patients, Journal of Neuroimmunology, vol.194, issue.1-2, pp.123-131, 2008. ,
DOI : 10.1016/j.jneuroim.2007.10.028
Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice, Brain Structure and Function, vol.93, issue.2, 2009. ,
DOI : 10.1007/s00429-009-0226-4
Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase, Journal of Neuroscience, vol.28, issue.46, pp.12039-12051, 2008. ,
DOI : 10.1523/JNEUROSCI.3568-08.2008
URL : https://hal.archives-ouvertes.fr/pasteur-00428978
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS, Proceedings of the National Academy of Sciences, vol.105, issue.46, pp.17913-17918, 2008. ,
DOI : 10.1073/pnas.0804610105
Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice, Proceedings of the National Academy of Sciences, vol.106, issue.49, pp.20960-20965, 2009. ,
DOI : 10.1073/pnas.0911405106
Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS, The American Journal of Human Genetics, vol.84, issue.1, pp.85-88, 2009. ,
DOI : 10.1016/j.ajhg.2008.12.010
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice, Science, vol.302, issue.5642, pp.113-117, 2003. ,
DOI : 10.1126/science.1086071
Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1, J Immunol, vol.161, pp.978-984, 1998. ,
Neuroinflammation, COX-2, and ALS???a dual role?, Experimental Neurology, vol.187, issue.1, pp.1-10, 2004. ,
DOI : 10.1016/j.expneurol.2003.12.009
Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients, European Journal of Neurology, vol.128, issue.3, pp.398-404, 2009. ,
DOI : 10.1111/j.1468-1331.2009.02815.x
Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues, Brain, vol.127, issue.11, pp.2518-2532, 2004. ,
DOI : 10.1093/brain/awh273
The origin and differentiation of microglial cells during development, Progress in Neurobiology, vol.56, issue.2, pp.173-189, 1998. ,
DOI : 10.1016/S0301-0082(98)00035-5
Trial of celecoxib in amyotrophic lateral sclerosis, Annals of Neurology, vol.24, issue.1, pp.22-31, 2006. ,
DOI : 10.1002/ana.20903
The Proinflammatory Action of Microglial P2 Receptors Is Enhanced in SOD1 Models for Amyotrophic Lateral Sclerosis, The Journal of Immunology, vol.183, issue.7, pp.4648-4656, 2009. ,
DOI : 10.4049/jimmunol.0901212
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects, Blood, vol.99, issue.1, pp.111-120, 2002. ,
DOI : 10.1182/blood.V99.1.111
ATP mediates rapid microglial response to local brain injury in vivo, Nature Neuroscience, vol.19, issue.6, pp.752-758, 2005. ,
DOI : 10.1523/JNEUROSCI.2294-04.2004
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I??B?? induction and block of NF??B and iNOS activation, Journal of Neurochemistry, vol.22, issue.2, pp.494-501, 2004. ,
DOI : 10.1046/j.1471-4159.2003.02210.x
Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria, Proceedings of the National Academy of Sciences, vol.103, issue.18, pp.7142-7147, 2006. ,
DOI : 10.1073/pnas.0602046103
Non???cell autonomous effect of glia on motor neurons in an embryonic stem cell???based ALS model, Nature Neuroscience, vol.252, issue.5, pp.608-614, 2007. ,
DOI : 10.1038/nn1876
Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model, The Journal of Cell Biology, vol.105, issue.2, pp.193-199, 2005. ,
DOI : 10.1016/S0896-6273(00)80086-0
Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity, Molecular Therapy, vol.16, issue.6, pp.1056-1064, 2008. ,
DOI : 10.1038/mt.2008.60
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS, Annals of Neurology, vol.155, issue.6, pp.771-778, 2002. ,
DOI : 10.1002/ana.10374
Collapsin Response Mediator Protein 4a (CRMP4a) Is Upregulated in Motoneurons of Mutant SOD1 Mice and Can Trigger Motoneuron Axonal Degeneration and Cell Death, Journal of Neuroscience, vol.30, issue.2, pp.785-796, 2010. ,
DOI : 10.1523/JNEUROSCI.5411-09.2010
Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis, Molecular Brain Research, vol.95, issue.1-2, pp.172-178, 2001. ,
DOI : 10.1016/S0169-328X(01)00242-X
Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis), Life Sciences, vol.67, issue.1, pp.53-59, 2000. ,
DOI : 10.1016/S0024-3205(00)00602-0
Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis, Archives of Neurology, vol.50, issue.1, pp.30-36, 1993. ,
DOI : 10.1001/archneur.1993.00540010026013
Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation, Journal of Neurochemistry, vol.56, issue.1, pp.170-178, 2007. ,
DOI : 10.1073/pnas.87.13.5006
Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis, Neuroscience, vol.90, issue.4, pp.1483-1492, 1999. ,
DOI : 10.1016/S0306-4522(98)00492-8
Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene, Journal of Neuroinflammation, vol.4, issue.1, p.9, 2007. ,
DOI : 10.1186/1742-2094-4-9
Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy, Journal of Neuroscience Research, vol.10, issue.1, pp.74-82, 2001. ,
DOI : 10.1002/jnr.1198
Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears ??-amyloid in a mouse model of Alzheimer disease, Journal of Clinical Investigation, vol.115, issue.9, pp.2423-2433, 2005. ,
DOI : 10.1172/JCI23241DS1
Implications of blood-brain barrier disruption in ALS, Amyotrophic Lateral Sclerosis, vol.11, issue.6, pp.375-376, 2008. ,
DOI : 10.1073/pnas.93.7.3155
Intravenous Administration of Human Umbilical Cord Blood Cells in a Mouse Model of Amyotrophic Lateral Sclerosis: Distribution, Migration, and Differentiation, Journal of Hematotherapy & Stem Cell Research, vol.12, issue.3, pp.255-270, 2003. ,
DOI : 10.1089/152581603322022990
P3-287: TDP-43 A315T mutation in familial motor neuron disease, Alzheimer's & Dementia, vol.4, issue.4, pp.535-538, 2008. ,
DOI : 10.1016/j.jalz.2008.05.1855
Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration, J Neurosci, vol.20, pp.660-665, 2000. ,
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial, The Lancet Neurology, vol.6, issue.12, pp.1045-1053, 2007. ,
DOI : 10.1016/S1474-4422(07)70270-3
Absence of Tumor Necrosis Factor-?? Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations, Journal of Neuroscience, vol.26, issue.44, pp.11397-11402, 2006. ,
DOI : 10.1523/JNEUROSCI.0602-06.2006
Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase, Experimental Neurology, vol.220, issue.2, pp.267-275, 2009. ,
DOI : 10.1016/j.expneurol.2009.08.021
Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase, Journal of Neuroscience, vol.28, issue.41, pp.10234-10244, 2008. ,
DOI : 10.1523/JNEUROSCI.3494-08.2008
Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis, Journal of Neuroinflammation, vol.7, issue.1, 2010. ,
DOI : 10.1186/1742-2094-7-8
Macrophage Systems in Peripheral Nerves. A Review, Journal of Neuropathology and Experimental Neurology, vol.52, issue.6, pp.553-560, 1993. ,
DOI : 10.1097/00005072-199311000-00001
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis, Proceedings of the National Academy of Sciences, vol.106, issue.51, pp.21777-21782, 2009. ,
DOI : 10.1073/pnas.0902174106
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation, Science, vol.264, issue.5166, pp.1772-1775, 1994. ,
DOI : 10.1126/science.8209258
Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS, Neurobiology of Disease, vol.26, issue.1, pp.146-152, 2007. ,
DOI : 10.1016/j.nbd.2006.12.013
Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS, Glia, vol.190, issue.3, pp.249-256, 1998. ,
DOI : 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#
Microglia: active sensor and versatile effector cells in the normal and pathologic brain, Nature Neuroscience, vol.24, issue.11, pp.1387-1394, 2007. ,
DOI : 10.1038/nn1997
SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model, Journal of Clinical Investigation, vol.118, pp.659-670, 2008. ,
DOI : 10.1172/JCI34060DS1
The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS, Molecular and Cellular Neuroscience, vol.31, issue.3, pp.427-437, 2006. ,
DOI : 10.1016/j.mcn.2005.10.016
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue, Annals of Neurology, vol.27, issue.suppl 1, pp.221-235, 2004. ,
DOI : 10.1002/ana.10805
Message and protein-level elevation of tumor necrosis factor ?? (TNF??) and TNF??-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis, Neurobiology of Disease, vol.14, issue.1, pp.74-80, 2003. ,
DOI : 10.1016/S0969-9961(03)00087-1
Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200), Science, vol.290, issue.5497, pp.1768-1771, 2000. ,
DOI : 10.1126/science.290.5497.1768
Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis, Growth Hormone & IGF Research, vol.17, issue.6, pp.472-479, 2007. ,
DOI : 10.1016/j.ghir.2007.06.002
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS), Proceedings of the National Academy of Sciences, vol.99, issue.3, pp.1604-1609, 2002. ,
DOI : 10.1073/pnas.032539299
Non???cell autonomous toxicity in neurodegenerative disorders: ALS and beyond, The Journal of Cell Biology, vol.22, issue.6, pp.761-772, 2009. ,
DOI : 10.1146/annurev.neuro.23.1.217
The function of microglia through purinergic receptors: Neuropathic pain and cytokine release, Pharmacology & Therapeutics, vol.109, issue.1-2, pp.210-226, 2006. ,
DOI : 10.1016/j.pharmthera.2005.07.001
Neuron-Specific Expression of Mutant Superoxide Dismutase Is Sufficient to Induce Amyotrophic Lateral Sclerosis in Transgenic Mice, Journal of Neuroscience, vol.28, issue.9, pp.2075-2088, 2008. ,
DOI : 10.1523/JNEUROSCI.5258-07.2008
Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?, Annals of Neurology, vol.280, issue.6, pp.553-559, 2007. ,
DOI : 10.1002/ana.21319
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis, Nature Genetics, vol.69, issue.5, pp.572-574, 2008. ,
DOI : 10.1083/jcb.200702115
Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: Impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage???colony stimulating factor???deficient mice, The Journal of Comparative Neurology, vol.436, issue.2, pp.182-201, 2001. ,
DOI : 10.1002/cne.1060.abs
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model, Science, vol.301, issue.5634, pp.839-842, 2003. ,
DOI : 10.1126/science.1086137
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue, Am J Pathol, vol.140, pp.691-707, 1992. ,
Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis, Experimental Neurology, vol.191, issue.2, pp.331-336, 2005. ,
DOI : 10.1016/j.expneurol.2004.10.007
Thalidomide and Lenalidomide Extend Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis, Journal of Neuroscience, vol.26, issue.9, pp.2467-2473, 2006. ,
DOI : 10.1523/JNEUROSCI.5253-05.2006
Microglia: a sensor for pathological events in the CNS, Trends in Neurosciences, vol.19, issue.8, pp.312-318, 1996. ,
DOI : 10.1016/0166-2236(96)10049-7
Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis, Neurobiology of Disease, vol.10, issue.3, pp.268-278, 2002. ,
DOI : 10.1006/nbdi.2002.0487
Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis, European Journal of Neurology, vol.29, issue.Pt 3, pp.771-774, 2009. ,
DOI : 10.1111/j.1468-1331.2009.02560.x
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis, Science, vol.323, issue.5918, pp.1205-1208, 2009. ,
DOI : 10.1126/science.1166066
Effect of recombinant human insulin-like growth factor-I on progression of ALS: A placebo-controlled study, Neurology, vol.49, issue.6, pp.1621-1630, 1997. ,
DOI : 10.1212/WNL.49.6.1621
Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis, Annals of Neurology, vol.1, issue.3, pp.365-372, 1990. ,
DOI : 10.1002/ana.410280311
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, Journal of Neuroimmunology, vol.183, issue.1-2, pp.60-68, 2007. ,
DOI : 10.1016/j.jneuroim.2006.11.009
Turnover of resident microglia in the normal adult mouse brain, Neuroscience, vol.48, issue.2, pp.405-415, 1992. ,
DOI : 10.1016/0306-4522(92)90500-2
Minocycline for patients with ALS, The Lancet Neurology, vol.7, issue.2, pp.119-120, 2008. ,
DOI : 10.1016/S1474-4422(08)70006-1
Amoeboid and ramified microglia: Their interrelationship and response to brain injury, Glia, vol.136, issue.1, pp.39-47, 1992. ,
DOI : 10.1002/glia.440060106
Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS, Brain Research, vol.1185, pp.256-265, 2007. ,
DOI : 10.1016/j.brainres.2007.09.034
Focal transplantation???based astrocyte replacement is neuroprotective in a model of motor neuron disease, Nature Neuroscience, vol.2, issue.11, pp.1294-1301, 2008. ,
DOI : 10.1038/nn.2210
CR1, Glia, vol.297, issue.13, pp.1410-1419, 2009. ,
DOI : 10.1002/glia.20859
EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis, Annals of Neurology, vol.48, issue.481, pp.304-314, 2008. ,
DOI : 10.1002/ana.21437
Use of carbon labeling to demonstrate the role of blood monocytes as precursors of the ?ameboid cells? present in the corpus callosum of postnatal rats, The Journal of Comparative Neurology, vol.5, issue.3, pp.631-657, 1980. ,
DOI : 10.1002/cne.901930304
Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease, J Neurosci, vol.22, pp.4825-4832, 2002. ,
Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2, Journal of Biological Chemistry, vol.284, issue.6, pp.3691-3699, 2009. ,
DOI : 10.1074/jbc.M804446200
Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons, Proceedings of the National Academy of Sciences, vol.104, issue.18, pp.7319-7326, 2007. ,
DOI : 10.1073/pnas.0702230104
Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice, Proceedings of the National Academy of Sciences, vol.106, issue.11, pp.4465-4470, 2009. ,
DOI : 10.1073/pnas.0813339106
Guidelines for preclinical animal research in ALS/MND: A consensus meeting, Amyotrophic Lateral Sclerosis, vol.347, issue.1-2, pp.38-45, 2010. ,
DOI : 10.1073/pnas.0530191100
Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis, European Journal of Neuroscience, vol.57, issue.6, pp.1527-1534, 2003. ,
DOI : 10.1038/sj.onc.1201178
Redox modifier genes in amyotrophic lateral sclerosis in mice, Journal of Clinical Investigation, vol.117, issue.10, pp.2913-2919, 2007. ,
DOI : 10.1172/JCI31265DS1
Microglia Promote the Death of Developing Purkinje Cells, Neuron, vol.41, issue.4, pp.535-547, 2004. ,
DOI : 10.1016/S0896-6273(04)00069-8
URL : https://hal.archives-ouvertes.fr/hal-00077309
Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: Mechanisms of mitochondriopathy and cell death, The Journal of Comparative Neurology, vol.79, issue.1, pp.20-46, 2007. ,
DOI : 10.1002/cne.21160
Glial changes following an excitotoxic lesion in the CNS???I. Microglia/macrophages, Neuroscience, vol.45, issue.3, pp.529-539, 1991. ,
DOI : 10.1016/0306-4522(91)90268-S
Microglia in degenerative neurological disease, Glia, vol.2, issue.1, pp.84-92, 1993. ,
DOI : 10.1002/glia.440070114
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Research Reviews, vol.21, issue.2, pp.195-218, 1995. ,
DOI : 10.1016/0165-0173(95)00011-9
Inflammatory processes in amyotrophic lateral sclerosis, Muscle & Nerve, vol.58, issue.4, pp.459-470, 2002. ,
DOI : 10.1002/mus.10191
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities, EMBO J, vol.15, pp.5647-5658, 1996. ,
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial, Amyotrophic Lateral Sclerosis, vol.6, issue.1, pp.378-383, 2009. ,
DOI : 10.1080/17482960701875896
The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS, Experimental Neurology, vol.207, issue.1, pp.52-63, 2007. ,
DOI : 10.1016/j.expneurol.2007.05.016
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions, Nature Neuroscience, vol.72, issue.12, pp.1544-1553, 2007. ,
DOI : 10.1038/nn2015
Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis, Proceedings of the National Academy of Sciences, vol.103, issue.51, pp.19546-19551, 2006. ,
DOI : 10.1073/pnas.0609411103
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons, Nature Neuroscience, vol.67, issue.5, pp.615-622, 2007. ,
DOI : 10.1016/S0092-8674(00)80323-2
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799799
Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis, Journal of the Neurological Sciences, vol.235, issue.1-2, pp.61-68, 2005. ,
DOI : 10.1016/j.jns.2005.04.011
Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis, Neurological Research, vol.5, issue.7, pp.768-772, 2005. ,
DOI : 10.1179/016164105X39860
Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients, Neurological Research, vol.153, issue.8, pp.772-776, 2007. ,
DOI : 10.1016/j.jneuroim.2003.08.042
Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes, Journal of Neurology, vol.28, issue.8, pp.1228-1235, 2009. ,
DOI : 10.1007/s00415-009-5097-3
Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study, Amyotroph Lateral, vol.Scler, pp.1-7, 2009. ,
Lenalidomide (Revlimid??) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis, Experimental Neurology, vol.220, issue.1, pp.191-197, 2009. ,
DOI : 10.1016/j.expneurol.2009.08.028
Exacerbation of Motor Neuron Disease by Chronic Stimulation of Innate Immunity in a Mouse Model of Amyotrophic Lateral Sclerosis, Journal of Neuroscience, vol.24, issue.6, pp.1340-1349, 2004. ,
DOI : 10.1523/JNEUROSCI.4786-03.2004
Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin-1? in neurodegeneration, Annals of Neurology, vol.19, issue.5, pp.630-639, 2001. ,
DOI : 10.1002/ana.1256
Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo, Science, vol.308, issue.5726, pp.1314-1318, 2005. ,
DOI : 10.1126/science.1110647
Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis, Brain Research, vol.1296, pp.216-224, 2009. ,
DOI : 10.1016/j.brainres.2009.08.012
Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord, Annals of Neurology, vol.111, issue.6, pp.730-740, 2001. ,
DOI : 10.1002/ana.1252
Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice, Experimental Neurology, vol.201, issue.1, pp.120-130, 2006. ,
DOI : 10.1016/j.expneurol.2006.03.028
The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features, European Journal of Neurology, vol.27, issue.Suppl. 1, 2009. ,
DOI : 10.1111/j.1468-1331.2009.02896.x
Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain, Neuroscience, vol.15, issue.2, pp.313-326, 1985. ,
DOI : 10.1016/0306-4522(85)90215-5
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis, Brain, vol.131, issue.12, pp.3335-3347, 2008. ,
DOI : 10.1093/brain/awn243
Circulating levels of tumour necrosis factor-?? and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis, Neuroscience Letters, vol.287, issue.3, pp.211-214, 2000. ,
DOI : 10.1016/S0304-3940(00)01177-0
A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis, The FASEB Journal, vol.17, pp.725-727, 2003. ,
DOI : 10.1096/fj.02-0876fje
Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment, J Neurosci, vol.21, pp.3369-3374, 2001. ,
Targeting genemodified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in the mouse, Nature Medicine, vol.7, issue.12, pp.1356-1361, 2001. ,
DOI : 10.1038/nm1201-1356
Oxidation-induced Misfolding and Aggregation of Superoxide Dismutase and Its Implications for Amyotrophic Lateral Sclerosis, Journal of Biological Chemistry, vol.277, issue.49, pp.47551-47556, 2002. ,
DOI : 10.1074/jbc.M207356200
Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL, Proceedings of the National Academy of Sciences, vol.103, issue.15, pp.6007-6012, 2006. ,
DOI : 10.1073/pnas.0508774103
URL : https://hal.archives-ouvertes.fr/hal-00088942
Motoneuron Death Triggered by a Specific Pathway Downstream of Fas, Neuron, vol.35, issue.6, pp.1067-1083, 2002. ,
DOI : 10.1016/S0896-6273(02)00905-4
Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury, Nature Genetics, vol.336, issue.1, pp.43-47, 1996. ,
DOI : 10.1038/ng0596-43
RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis, vol.2, issue.5, pp.283-287, 2007. ,
DOI : 10.1080/146608200300079536
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation, Nature, vol.391, issue.6662, pp.79-82, 1998. ,
DOI : 10.1038/34178
Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis., Proceedings of the National Academy of Sciences, vol.92, issue.3, pp.689-693, 1995. ,
DOI : 10.1073/pnas.92.3.689
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, vol.362, issue.6415, pp.59-62, 1993. ,
DOI : 10.1038/362059a0
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, vol.362, issue.6415, p.362, 1993. ,
DOI : 10.1038/362059a0
Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis, Journal of Medical Virology, vol.4, issue.3, pp.222-226, 1996. ,
DOI : 10.1002/(SICI)1096-9071(199603)48:3<222::AID-JMV2>3.0.CO;2-A
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis, Annals of Neurology, vol.20, issue.1, pp.73-84, 1995. ,
DOI : 10.1002/ana.410380114
Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis, PLoS Genetics, vol.20, issue.9, p.18802454, 2008. ,
DOI : 10.1371/journal.pgen.1000193.s006
Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1, NeuroReport, vol.20, issue.16, pp.1450-1455, 2009. ,
DOI : 10.1097/WNR.0b013e328331e8fa
Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis, Journal of Neuropathology & Experimental Neurology, vol.67, issue.11, pp.1055-1062, 2008. ,
DOI : 10.1097/NEN.0b013e31818b4906
A Neuroprotective Function for the Hematopoietic Protein Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF), Journal of Cerebral Blood Flow & Metabolism, vol.64, issue.1, pp.29-43, 2008. ,
DOI : 10.1038/sj.jcbfm.9600496
Neuroscience: Standard model, Nature, vol.453, issue.7205, pp.682-685, 2008. ,
DOI : 10.1126/science.1134108
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis, Journal of Clinical Investigation, vol.115, issue.8, pp.2083-2098, 2005. ,
DOI : 10.1172/JCI23559DS1
The Oral Antidiabetic Pioglitazone Protects from Neurodegeneration and Amyotrophic Lateral Sclerosis-Like Symptoms in Superoxide Dismutase-G93A Transgenic Mice, Journal of Neuroscience, vol.25, issue.34, pp.7805-7812, 2005. ,
DOI : 10.1523/JNEUROSCI.2038-05.2005
Design, power, and interpretation of studies in the standard murine model of ALS, Amyotrophic Lateral Sclerosis, vol.93, issue.1, pp.4-15, 2008. ,
DOI : 10.1523/JNEUROSCI.5253-05.2006
Thymic Involution in Amyotrophic Lateral Sclerosis, J Cell Mol Med, vol.PMID, 2009. ,
Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients, Brain Research, vol.917, issue.1, pp.97-104, 2001. ,
DOI : 10.1016/S0006-8993(01)02926-2
Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia, The FASEB Journal, vol.18, pp.998-1000, 2004. ,
DOI : 10.1096/fj.04-1517fje
Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden, Neurology, vol.62, issue.10, pp.1758-1765, 2004. ,
DOI : 10.1212/WNL.62.10.1758
Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis, Annals of Neurology, vol.16, issue.4, pp.696-699, 1998. ,
DOI : 10.1002/ana.410440419
Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis, Glia, vol.294, issue.7, pp.744-753, 2006. ,
DOI : 10.1002/glia.20331
Survival in a transgenic model of fals is independent of inos expression, Annals of Neurology, vol.72, issue.2, p.273, 2001. ,
DOI : 10.1002/ana.1104
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial, Neurology, vol.71, issue.22, pp.1770-1775, 2008. ,
DOI : 10.1212/01.wnl.0000335970.78664.36
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis, Science, vol.319, issue.5870, pp.1668-1672, 2008. ,
DOI : 10.1126/science.1154584
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial, Amyotrophic Lateral Sclerosis, vol.53, issue.5-6, pp.393-404, 2009. ,
DOI : 10.1016/j.jneuroim.2007.10.028
Microglia as neuroprotective, immunocompetent cells of the CNS, Glia, vol.57, issue.2, pp.133-139, 2002. ,
DOI : 10.1002/glia.10154
Search for persistent infection with poliovirus or other enteroviruses in amyotrophic lateral sclerosis-motor neurone disease, Neuromuscular Disorders, vol.5, issue.6, pp.457-465, 1995. ,
DOI : 10.1016/0960-8966(95)00002-5
The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis, Neurology, vol.50, issue.3, pp.772-776, 1998. ,
DOI : 10.1212/WNL.50.3.772
Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis, Clin Neuropathol, vol.8, pp.289-294, 1989. ,
Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis, Neuropathology and Applied Neurobiology, vol.51, issue.5, pp.401-410, 1990. ,
DOI : 10.1002/ana.410140103
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study, Neurobiology of Disease, vol.15, issue.3, pp.601-609, 2004. ,
DOI : 10.1016/j.nbd.2003.12.012
Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis, Proceedings of the National Academy of Sciences, vol.104, issue.7, pp.2495-2500, 2007. ,
DOI : 10.1073/pnas.0606201104
Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis, Nature Neuroscience, vol.274, issue.1, pp.108-118, 2006. ,
DOI : 10.1038/nn1603
Crosstalk between astrocytes and motor neurons: What is the message?, Experimental Neurology, vol.211, issue.1, pp.1-6, 2008. ,
DOI : 10.1016/j.expneurol.2008.01.008
Minocycline delays disease onset and mortality in a transgenic model of ALS, Neuroreport, vol.13, issue.8, pp.1067-1070, 2002. ,
DOI : 10.1097/00001756-200206120-00018
The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1762, issue.11-12, pp.1068-1082, 2006. ,
DOI : 10.1016/j.bbadis.2006.05.002
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6, Science, vol.323, issue.5918, pp.1208-1211, 2009. ,
DOI : 10.1126/science.1165942
Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis, Journal of Neuroscience, vol.28, issue.50, pp.13574-13581, 2008. ,
DOI : 10.1523/JNEUROSCI.4099-08.2008
Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis, Journal of Neurochemistry, vol.538, issue.3, pp.687-696, 2006. ,
DOI : 10.1111/j.1471-4159.2006.03742.x
Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients, Annals of Neurology, vol.354, issue.2, pp.249-253, 2001. ,
DOI : 10.1002/1531-8249(20010201)49:2<249::AID-ANA46>3.0.CO;2-3
Fibrillar Inclusions and Motor Neuron Degeneration in Transgenic Mice Expressing Superoxide Dismutase 1 with a Disrupted Copper-Binding Site, Neurobiology of Disease, vol.10, issue.2, pp.128-138, 2002. ,
DOI : 10.1006/nbdi.2002.0498
Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse, Human Molecular Genetics, vol.18, issue.9, pp.1642-1651, 2009. ,
DOI : 10.1093/hmg/ddp085
The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis, Neurobiology of Disease, vol.35, issue.2, pp.234-240, 2009. ,
DOI : 10.1016/j.nbd.2009.05.002
Reduced number and altered morphology of microglial cells in colony stimulating factor-1-deficient osteopetrotic op/op mice, Brain Research, vol.804, issue.1, pp.135-139, 1998. ,
DOI : 10.1016/S0006-8993(98)00618-0
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration, Proceedings of the National Academy of Sciences, vol.106, issue.44, pp.18809-18814, 2009. ,
DOI : 10.1073/pnas.0908767106
Increased cytotoxic potential of microglia from ALS-transgenic mice, Glia, vol.417, issue.2, pp.179-182, 2004. ,
DOI : 10.1002/glia.20062
Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation, Journal of Experimental Medicine, vol.156, issue.5, pp.1516-1527, 1982. ,
DOI : 10.1084/jem.156.5.1516
Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration, Journal of Neuroimmunology, vol.144, issue.1-2, pp.139-142, 2003. ,
DOI : 10.1016/j.jneuroim.2003.08.042
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration, Proceedings of the National Academy of Sciences, vol.107, issue.8, pp.3858-3863, 2010. ,
DOI : 10.1073/pnas.0912417107
An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria, Neuron, vol.14, issue.6, pp.1105-1116, 1995. ,
DOI : 10.1016/0896-6273(95)90259-7
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice, Proceedings of the National Academy of Sciences, vol.103, issue.32, pp.12132-12137, 2006. ,
DOI : 10.1073/pnas.0603670103
Inflammation in Neurodegenerative Disease???A Double-Edged Sword, Neuron, vol.35, issue.3, pp.419-432, 2002. ,
DOI : 10.1016/S0896-6273(02)00794-8
microglia are more neurotoxic relative to wild-type microglia, Journal of Neurochemistry, vol.99, issue.6, pp.2008-2019, 2007. ,
DOI : 10.1111/j.1471-4159.2007.04677.x
Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice, Proceedings of the National Academy of Sciences, vol.105, issue.21, pp.7594-7599, 2008. ,
DOI : 10.1073/pnas.0802556105
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis, Nature Neuroscience, vol.96, issue.3, pp.251-253, 2008. ,
DOI : 10.1038/nn2047
Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy, Neurology, vol.57, issue.6, pp.952-956, 2001. ,
DOI : 10.1212/WNL.57.6.952
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord, BMC Neurology, vol.3, issue.1, p.12, 2006. ,
DOI : 10.1016/S1471-4892(02)00004-8
Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis, Journal of Neurochemistry, vol.80, issue.1, pp.158-167, 2002. ,
DOI : 10.1046/j.0022-3042.2001.00683.x
A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window, Proceedings of the National Academy of Sciences, vol.96, issue.23, pp.13496-13500, 1999. ,
DOI : 10.1073/pnas.96.23.13496
Extracellular mutant SOD1 induces microglial-mediated motoneuron injury, Glia, vol.99, issue.2, pp.231-243, 2010. ,
DOI : 10.1002/glia.20919
Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia, Journal of Neurochemistry, vol.63, issue.4, pp.1176-1187, 2006. ,
DOI : 10.1016/0167-4889(94)00207-U
Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity, Brain Res, pp.1073-1074, 2006. ,
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration, Nature Neuroscience, vol.66, issue.4, pp.420-422, 2008. ,
DOI : 10.1038/nn2073
Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells, Journal of Clinical Investigation, vol.119, pp.3437-3449, 2009. ,
DOI : 10.1172/JCI38476DS1
Transgenic Rat Model of Neurodegeneration Caused by Mutation in the TDP Gene, PLoS Genetics, vol.15, issue.3, p.20361056, 2010. ,
DOI : 10.1371/journal.pgen.1000887.s005
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice, Nature, vol.419, issue.6884, pp.74-78, 2002. ,
DOI : 10.1038/417074a